Recognizing the value of anticancer treatments based on progression-free survival and overall survival may help decision making in healthcare policy. We aimed to measure and compare the impact of dise
The reported Rate Ratios describe the variations in costs expressed as a multiplicative factor for patients presenting the associated characteristic compared to those who did not, all other things bei
Model with functions depending on Age, Male, BP (Blood Pressure). There are 3 disease states: Healthy, Sick, and Dead, where the Dead state is terminal. The yearly transition probabilities are: Health
